CRISPR-Cas9, the "genetic scissors", creates new potential for curing diseases; but treatments must be reliable. In a new study, researchers have discovered that the method can give rise to unforeseen changes in DNA that can be inherited by the next generation.
Search jobs 05-May-2021 Olink announces first core lab running the Olink Explore platform in Europe, making it available for more researchers
Olink announces first core lab running the Olink Explore platform in Europe, making it available for more researchers
UPPSALA, Sweden, May 04, 2021 (GLOBE NEWSWIRE)
Olink Holding AB (publ) (Nasdaq: OLK) today announced that its Olink® Explore 1536/384 platform is now available to researchers in Europe through the SciLifeLab National Genomics Infrastructure (NGI) and the Affinity Proteomics Uppsala unit at SciLifeLab Clinical and Immunological platform (APU) by their combined capability SciLifeLab Explore lab.
This is the first core lab in Europe certified to offer the Olink Explore platform, comprising four protein biomarker panels for cardiovascular and metabolic diseases, oncology, neurology and inflammation. The platform enables researchers to define protein signatures that provide